REQUEST A DEMO
Total
USD $0.00
Search more companies

Rootloc Co. Ltd. (South Korea)

Main Activities: Electromedical and Electrotherapeutic Apparatus Manufacturing
Full name: Rootloc Co. Ltd. Profile Updated: June 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company that engages in the manufacture of orthopedic and body correction devices. The Company provides medical device solutions to patients with artificial joints, including knee, hip, shoulder, elbow, wrist and hand. The Company's main solutions include knee arthroplasties, antibiotic-loaded bone cements and hip arthroplasties. The Company was founded on May 15, 2014,and its shares are listed on KONEX Exchange on December 24, 2020.

Headquarters
B125, Daeryung Post Tower 5-Cha, 68, Digital-Ro 9-Gil, Geumcheon-Gu
Seoul; Seoul;

Contact Details: Purchase the Rootloc Co. Ltd. report to view the information.

Website: http://rootloc.com

Basic Information
Total Employees:
Purchase the Rootloc Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Rootloc Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Rootloc Co. Ltd. report to view the information.
Incorporation Date:
December 06, 2025
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Company Performance
Financial values in the chart are available after Rootloc Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
82.86%
Total operating revenue
81.69%
Operating profit (EBIT)
1.21%
EBITDA
31.17%
Net Profit (Loss) for the Period
4.86%
Total assets
14.33%
Total equity
61.69%
Operating Profit Margin (ROS)
30.3%
Net Profit Margin
40.59%
Return on Equity (ROE)
396.88%
Debt to Equity Ratio
-647.63%
Quick Ratio
-0.45%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?